Category: commercialisation

  • BMS’ Catherine Owen on pharma commercialisation: the pharmaphorum podcast

    Episode 42 of the pharmaphorum podcast heard from Catherine Owen, who’s senior vice president of major markets at Bristol Myers Squibb, about the future of pharma commercialisation and communications. As part of that we looked at how she approaches the 19 markets she oversees and the challenges that can present. And Catherine suggests some areas […]

  • Deep Dive: Communications and Commercialisation

    The COVID-19 pandemic kickstarted a period of profound change in how the pharmaceutical industry approaches both communications and commercialisation. In some cases it was an accelerant for existing plans, but it has also caused some new shifts in the landscape, shifts that have yet to be completed. This issue assesses European pharma’s approach to strategic […]

  • The post-COVID future of physician sample access and engagement

    Building modern commercialisation strategies requires pharma to find the right balance of old ways and new approaches, says Cardinal Health’s Jennifer Baughman. COVID-19 has fundamentally changed much of our lives – from how we interact with people to how we work. For the pharma industry, the pandemic’s changes were both abrupt and industry-altering, requiring companies […]